Tan Li
Net worth: 599 M $ as of 2026-05-30
Net worth: 599 M $ as of 2026-05-30
Tan Li founded Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Ms. Li is Executive Director & Deputy General Manager at this company and Executive Partner at Urumqi Jintiantu Equity Investment Partnership LP. Ms. Li is also on the board of Kymab Ltd., Shenzhen Techdow Pharmaceutical Co., Ltd., Shenzhen Duopule Industrial Development Co., Ltd. and Kymab Group Ltd. She received an undergraduate degree from Sichuan University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-09-29 | 408,041,280 ( 32.72% ) | 599 M $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. | Founder | 1998-04-20 |
Urumqi Jintiantu Equity Investment Partnership LP | Corporate Officer/Principal | 2013-08-08 |
Shenzhen Techdow Pharmaceutical Co., Ltd. | Director/Board Member | - |
Shenzhen Duopule Industrial Development Co., Ltd.
Shenzhen Duopule Industrial Development Co., Ltd. Wholesale DistributorsDistribution Services Distributes biochemical products | Director/Board Member | 2014-01-12 |
Kymab Ltd.
Kymab Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops human monoclonal antibody drugs | Director/Board Member | - |
Kymab Group Ltd.
Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops human monoclonal antibody drugs | Director/Board Member | 2017-01-19 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 7 |
|---|---|
Sichuan University
Sichuan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in production of heparin products | Health Technology |
Urumqi Jintiantu Equity Investment Partnership LP | |
Kymab Ltd.
Kymab Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops human monoclonal antibody drugs | Health Technology |
Shenzhen Techdow Pharmaceutical Co., Ltd. | |
Shenzhen Duopule Industrial Development Co., Ltd.
Shenzhen Duopule Industrial Development Co., Ltd. Wholesale DistributorsDistribution Services Distributes biochemical products | Distribution Services |
Kymab Group Ltd.
Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops human monoclonal antibody drugs | Health Technology |
Select your edition
All financial news and data tailored to specific country editions